Delivery of Synthetic Interleukin‐22 mRNA to Hepatocytes via Lipid Nanoparticles Alleviates Liver Injury
Small · 2024-11 · 20 (45)
DOI: 10.1002/smll.202401499 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 31.07.2024. Verfasst von Hanxiang Ouyang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 31000…. Hauptthemen laut MEDLINE: Interleukin-22, Interleukins, Hepatocytes, Nanoparticles. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Key Research and Development Program of Zhejiang Province, National Natural Science Foundation of China, Central Guidance on Local Science and Technology Development Fund of Zhejiang Province.
Abstract (Originalsprache)
Hepatocellular injury, a pivotal contributor to liver diseases, particularly hepatitis, lacks effective pharmacological treatments. Interleukin‐22 (IL‐22), crucial for liver cell survival, shows potential in treating liver diseases by regulating repair and regeneration through signal transducer and activator of transcription 3 (STAT3) activation. However, the short half‐life and off‐target effects limit its clinical applications. To address these issues, lipid nanoparticles are employed to deliver synthetic IL‐22 mRNA (IL‐22/NP) for in situ IL‐22 expression in hepatocytes. The study reveals that IL‐22/NP exhibits liver‐targeted IL‐22 expression, with increased IL‐22 levels detected in the liver as early as 3 h postintravenous injection, lasting up to 96 h. Furthermore, IL‐22/NP activates STAT3 signaling in an autocrine or paracrine manner to upregulate downstream factors Bcl‐xL and CyclinD1, inhibiting hepatocyte apoptosis and promoting cell proliferation. The therapeutic efficacy of IL‐22/NP is demonstrated in both chronic and acute liver injury models, suggesting IL‐22 mRNA delivery as a promising treatment strategy for hepatitis and liver diseases involving hepatocellular injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary and Pancreatic Surgery, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310009, China.
- Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, Hangzhou, Zhejiang, 310009, China.
- Research Center of Diagnosis and Treatment Technology for Hepatocellular Carcinoma of Zhejiang Province, Hangzhou, Zhejiang, 310009, China.
- National Innovation Center for Fundamental Research on Cancer Medicine, Hangzhou, Zhejiang, 310009, China.
- Cancer Center, Zhejiang University, Hangzhou, Zhejiang, 310058, China.
- ZJU-Pujian Research & Development Center of Medical Artificial Intelligence for Hepatobiliary and Pancreatic Disease, Hangzhou, Zhejiang, 310058, China.
ORCID-Profile: Zhengwei Mao
Förderung
- Key Research and Development Program of Zhejiang Province
- National Natural Science Foundation of China
- Central Guidance on Local Science and Technology Development Fund of Zhejiang Province
- Key Project of Traditional Chinese Medicine Science and Technology Plan of Zhejiang Province
- Zhejiang University K.P. Chao's High Technology Development Foundation
- Fundamental Research Funds for the Central Universities
- Natural Science Foundation of Zhejiang Province
- Shenzhen Science and Technology Innovation Program
Zitieren
APA
Ouyang, H., Wei, S., Gao, B., Qian, X., Chen, Y., Lu, J., Ding, Y., Mao, Z., Du, Y., & Wang, W. (2024). Delivery of Synthetic Interleukin‐22 mRNA to Hepatocytes via Lipid Nanoparticles Alleviates Liver Injury. Small, 20(45). https://doi.org/10.1002/smll.202401499
Vancouver
Ouyang H, Wei S, Gao B, Qian X, Chen Y, Lu J, et al. Delivery of Synthetic Interleukin‐22 mRNA to Hepatocytes via Lipid Nanoparticles Alleviates Liver Injury. Small. 2024;20(45). doi:10.1002/smll.202401499
BibTeX
@article{Ouyang2024,
author = {Ouyang, Hanxiang and Wei, Shenyu and Gao, Bingqiang and Qian, Xiaohui and Chen, Yining and Lu, Jingxiong and Ding, Yuan and Mao, Zhengwei and Du, Yang and Wang, Weilin},
title = {Delivery of Synthetic Interleukin‐22 mRNA to Hepatocytes via Lipid Nanoparticles Alleviates Liver Injury},
journal = {Small},
year = {2024},
volume = {20},
number = {45},
doi = {10.1002/smll.202401499}
}
EUVIMED